Dimensional Fund Advisors
TNXP icon

Dimensional Fund Advisors’s Tonix Pharmaceuticals TNXP Stock Holding History

Dimensional Fund Advisors’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1
Closed -$20K – 3523
2022
Q2 		$20K Buy
+1
New +$73.8K ﹤0.01% 3444
2019
Q3 		– Hold
0
– -$14K – 3435
2019
Q2 		– Hold
0
– – – 3461
2019
Q1 		– Hold
0
– – – 3419
2018
Q4 		– Hold
0
– -$34K – 3460
2018
Q3 		– Hold
0
– – – 3403
2018
Q2 		– Hold
0
– – – 3222
2018
Q1 		– Hold
0
– – – 3261
2017
Q4 		– Hold
0
– – – 3242
2017
Q3 		– Hold
0
– – – 3286
2017
Q2 		– Hold
0
– – – 3311
2017
Q1 		– Hold
0
– – – 3300
2016
Q3 		– Hold
0
– -$169K – 3283
2016
Q2 		– Hold
0
– – – 3199
2016
Q1 		– Hold
0
– – – 3177
2015
Q4 		– Hold
0
– – – 3048
2015
Q3 		– Hold
0
– – – 3132
2015
Q1 		– Hold
0
– -$18K – 3393
2014
Q4 		– Hold
0
– – – 3427

Other funds holding TNXP

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors's TNXP Position: Q3 2022 in Review

Dimensional Fund Advisors sold out of Tonix Pharmaceuticals (TNXP) in Q3 2022, closing a stake of 1 share — an estimated $20K sold.

Dimensional Fund Advisors first reported a position in TNXP in Q2 2022 and held it in 1 quarter. The position peaked at $20K in Q2 2022. 19 funds tracked by Wall St. Rank hold TNXP as of Q3 2022.

  • Dimensional Fund Advisors reported no remaining Tonix Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1 Tonix Pharmaceuticals share in Q3 2022, an estimated $20K.
  • Dimensional Fund Advisors first reported a position in Tonix Pharmaceuticals in Q2 2022 and held it in 1 quarter.
  • Dimensional Fund Advisors's Tonix Pharmaceuticals position peaked at $20K in Q2 2022.
  • 19 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.